Genzyme Corp. (Nasdaq: GENZ) options continue to be active following reports Friday that Sanofi-Aventis (NYSE: SNY) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE